MAM
Enamor lifts the veil on luxe collab with Papa Don’t Preach
MUMBAI: If luxury had a heartbeat, Enamor’s newest collaboration would be its thrum bold, hypnotic and impossible to ignore. The lingerie brand has partnered with fashion powerhouse Papa Don’t Preach to debut a high-fashion curation wrapped in drama, desire and a dash of surreal storytelling, unveiled through a dark, cinematic film now live on Enamor’s official Instagram.
The campaign pulls viewers into a world where silk meets shadow and confidence meets choreography. With fluid movement, striking contrasts and dreamlike motifs, the film crafts an atmosphere that feels more like art cinema than fashion promo, a visual ode to women who refuse to be edited down.
Rooted in the spirit of a woman who is timeless, fearless and unapologetically herself, the collection celebrates individuality as its core luxury. Every piece balances boldness with refinement, embracing silhouettes and textures that echo power without losing elegance.
For Enamor, this collaboration is more than a creative experiment, it’s a natural progression of its design philosophy. By joining hands with Papa Don’t Preach, a brand known for its audacious aesthetic, Enamor expands its narrative for the modern, expressive consumer while retaining its own distinct design language.
The result? A curation that doesn’t just dress the body but amplifies the story of the woman wearing it unfiltered, unafraid and unforgettable.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
